<div id="readability-page-1">03:59 PM EST, 12/09/2025 (MT Newswires) -- Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 1%.The iShares Biotechnology ETF (IBB) fell 1.7%.In corporate news, Mirum Pharmaceuticals' ( MIRM ) acquisition of Bluejay Therapeutics expands its rare liver disease pipeline with brelovitug, a hepatitis delta virus therapy that has shown &#34;solid&#34; phase 2 results, Morgan Stanley said in a note Tuesday. Morgan Stanley kept its overweight rating and raised its price target to $95 from $81. Mirum shares were down 3.7%.Pfizer ( PFE ) said that it has signed an exclusive global collaboration and licensing deal with YaoPharma, a unit of Shanghai Fosun Pharmaceutical, to develop, make and commercialize YP05002 for chronic weight management. Pfizer ( PFE ) shares were down 1.7%.CVS Health ( CVS ) lifted its full-year outlook on Tuesday amid ongoing efforts to strengthen its core businesses, while the healthcare company said it expects earnings in 2026 to be higher than the previous year. Its shares rose 2.4%.Teleflex ( TFX ) said Tuesday it agreed to sell its Acute Care, Interventional Urology and OEM units for a combined $2.03 billion in cash. Its shares jumped 9.7%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MIRM

泰利福

辉瑞

西维斯

医疗保健股票下跌，纽约证券交易所医疗保健指数下跌 0.6%。Mirum Pharmaceuticals 收购了 Bluejay Therapeutics，扩展了其产品线。辉瑞与 YaoPharma 签署了合作协议。CVS Health 上调了全年展望，预计 2026 年收益将更高。泰利福以 20.3 亿美元出售了单位，推动股价上涨 9.7%

Sector Update: Health Care Stocks Softer Late Afternoon

- 健康护理股票下跌，NYSE 健康护理指数下降 0.6%。  
- Mirum Pharmaceuticals 收购 Bluejay Therapeutics，扩展肝病管线。  
- CVS Health 上调全年展望，Teleflex 同意出售多个单位。  

板块更新：下午晚些时候医疗保健板块股票表现疲软